# Cantharone for the Treatment of Perenial Warts

> **NCT03625960** · PHASE4 · COMPLETED · sponsor: **Wayne State University** · enrollment: 12 (actual)

## Conditions studied

- Wart, Genital

## Interventions

- **DRUG:** Cantharidin
- **DRUG:** Trichloroacetic Acid

## Key facts

- **NCT ID:** NCT03625960
- **Lead sponsor:** Wayne State University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06-15
- **Primary completion:** 2007-06-15
- **Final completion:** 2007-07-15
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2018-08-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03625960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03625960, "Cantharone for the Treatment of Perenial Warts". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03625960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*